McKinsey October 1, 2021
Anne Kayem, Jannik Podlesny, Stephen Simpson, and Henning Soller

Graphical processing units have the potential to be game changers, but healthcare companies must understand their use cases.

As data sets get larger and more complex, traditional data-processing methods are increasingly unable to deliver insights in a timely fashion. The world at the edge of a global pandemic is a timely example: the analysis of millions of medical records—including disease, treatment, and genomic information—could yield critical insights for doctors, researchers, and pharma companies that are exploring novel vaccine opportunities. Yet this highly complex task frequently overwhelms traditional computing.

In the healthcare industry, processing tens of millions of records to derive inferences and extract insights has been nearly impossible to date. With the further proliferation of data privacy and data localization,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Big Data, Biotechnology, Healthcare System, Pharma / Biotech, Privacy / Security, Technology
Biopharma M&A more than doubled in the first quarter compared to the year prior: report
Bruker brokers $392M deal for frayed NanoString
Pharma Pulse 4/18/24: Is it Fair Certain Biotech Investors Get an Early Look? The Health and Healthcare of Millennials & more
23andMine: CEO Wojcicki aims to take genetics company private
AI That Predicts Targeted Cancer Drug Response with Single-Cell Precision

Share This Article